Evolving indications for transcatheter mitral edge-to-edge repair
Key result
TEER may improve outcomes for high-risk MR patients beyond currently recognized indications.
Why the study?
High-risk patients with mitral regurgitation typically managed conservatively and excluded from major trials may benefit from TEER, motivating a discussion of its use beyond recognised indications.
Does transcatheter mitral edge-to-edge repair (TEER) provide clinical improvement in high-risk patients with mitral regurgitation beyond recognized indications?
Population
High-risk patients with mitral regurgitation not normally included in major trials
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
TEER may benefit high-risk MR patients; extends prior evidence across primary and secondary MR anatomies.
Structured PICO
Does transcatheter mitral edge-to-edge repair (TEER) provide clinical improvement in high-risk patients with mitral regurgitation beyond recognized indications?
P
Population
High-risk patients with mitral regurgitation (primary and secondary), including those with post-myocardial infarction MR, hypertrophic obstructive cardiomyopathy, and recurrent MR after surgical intervention
I
Intervention
Transcatheter mitral edge-to-edge repair (TEER)
TEER may offer clinical benefits in high-risk patients with mitral regurgitation who are unsuitable for surgery and fall outside current recognized indications.
Cite This Study
Shuvy et al. (2024) conducted a review in Mitral regurgitation. Transcatheter mitral edge-to-edge repair (TEER) was evaluated. Transcatheter mitral edge-to-edge repair (TEER) may offer clinical improvement for high-risk patients with mitral regurgitation beyond currently recognized indications.